Out In Front
Contact Us
Contact Us

Proactive Worldwide Blog

Keep up with the latest insights from Proactive's researchers, analysts, and thought leaders.

Benefits of CI for the Pharmaceutical Industry

The average time associated with bringing a new drug to market hovers around 10 years — with six or seven of those years spent in clinical trials. As such, the risks for pharmaceutical companies looking for a good ROI on their R&D efforts have never been greater. Besides the millions — and in many cases billions — of dollars spent on new drug development, pharmaceutical companies must contend with a myriad of other tactical, strategic and talent issues to ultimately successfully meet their business objectives.

Of course, at the same time, the call for more personalized and/or specialized drugs is increasing — along with the scientific breakthroughs that are making them a reality. And with the global pharmaceutical industry expected to grow by 5.8 percent so its net worth will be in excess of $1,150 billion by 2021, pharmaceutical companies that get their product development right stand to do exceedingly well now and in the foreseeable future.

Much like a targeted treatment developed to improve a particular patient’s condition, competitive intelligence — or CI — can be the game-changer in helping a specific pharma manufacturer better pressure test its strategic plans and tactical moves before implementing them — thereby preventing errors and unforeseen surprises.

The Competitive Advantage of Pharma-Specific CI

With the rise of CI, several companies in the sector offer their services without taking a unique approach to the organizations and industries they aim to help. Fortunately, at Proactive Worldwide, our approach couldn’t be more different. We have a dedicated team of doctorate-level analysts specialized in pharmaceutical and healthcare engagements, and our CI services are hand-tailored to the pharmaceutical industry as well as to the unique needs of each company we serve.

Here are just a few of the many outstanding benefits pharma companies can expect to take advantage of by trusting our Proactive Worldwide team to supply them with customized CI services:

  • Prioritize R&D spending: Through deep analysis of competitors’ objectives, both unmet needs and gaps in R&D spending can be identified and better prioritized.
  • Track market actions: By tracking who’s entering or leaving a market due to issues such as licensing and M&A activities, an organization can proactively defend and/or increase its market presence.
  • Monitor medical conferences: From the planning stages through post-conference reporting, knowing which scientific developments are most likely to impact an organization’s business strategy makes medical conference monitoring a proven way of enhancing the likelihood of that strategy meeting with success.
  • Assess potential investment activities: With clear reporting of potential investment activity in its market sector, a pharma company is capable of deciphering its competitors’ plans with sufficient time to take any necessary strategic actions.
  • Evaluate sales and conversion rates: Equipped with multidimensional market research, a pharmaceutical manufacturer can responsibly evaluate and strengthen its sales force structure as well as its approach to converting potential leads into definite sales.

Proactive Worldwide — Providing Custom CI for the Pharma Sector

Combining Ph.D.-level medical experts with MBA-level business analysts is what makes our team at Proactive Worldwide so successful in the pharmaceutical sector. To discover how our pharma-specific CI services can give your company the competitive advantage it deserves, contact us today.

MENU

Proactive Worldwide